2021 BRACE Award Venture Competition

The Asian Fund for Cancer Research is pleased to announce Chimera Bioengineering as the Winner of the 2021 BRACE Award Venture Competition. The start-up company is developing an innovative CAR-T cell therapeutic technology platform targeting solid tumors. After being chosen among six semi-finalists in the 17 September 2021 BRACE Award Venture Competition, and following extensive due diligence, Chimera Bioengineering has received US$500,000 in equity investment from AFCR. The new funding allows the company, whose technology and team are addressing cancers prevalent in Asian populations, to pursue proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.

In addition, Believer Inc. was selected as the Second Place Winner by the BRACE Award Venture Competition Judging Committee, and KYAN Therapeutics has been named Best Public Communicator as the result of earning the most online votes by viewers of its program application video. Watch the videos below and learn more about these and the other risk-taking, early stage cancer technology companies who advanced as 2021 BRACE Award Venture Competition semi-finalists. Each is based in Asia or battling cancers prevalent in our region or among Asian populations!